Dalmau-Bueno, Albert, Albert-Ballestar, Sergi, Mansilla, Rosa, Garcia-Altes, Anna. Health Status and Use of Healthcare Services of Undocumented Migrant Sex Workers in Catalonia: A Descriptive Study Using Administrative Registries.. International Journal of Environmental Research and Public Health. 2025; 22(11)DOI:10.3390/ijerph22111696. PMID:. IF:(Q/D).

Moreno, Vicente, Martin-Pardo, Carme, Medel, Javier, Monerris, Mar, Ferrándiz, Marta, Lorente, Luís, Server, Anna, Serrano, Ancor, Carnaval, Thiago, Montes, Antonio, Videla, Sebastián. Estimating the prevalence of chronic insomnia in patients with non-cancer chronic pain: Study protocol of a multicenter cross-sectional study. Medicine: Case Reports And Study Protocols. 2025; 6(6)DOI:10.1097/MD9.0000000000000386. PMID:. IF:(Q/D).

Jin, YH, Yan, SY, Yao, XM, Dahm, P, Alonso-Coello, P, Brignardello-Petersen, R, Keitz, S, Rylance, J, Cheung, M, Agoritsas, T, Kunkle, R, Murad, MH, Guyatt, G. Study protocol for developing the evaluation instrument of guideline adherence to GRADE approach (GRADE-Check). BMJ Open. 2025; 15(11)DOI:10.1136/bmjopen-2025-105534. PMID:41213689. IF:2.300(Q2/3D).

De Santis, M, Redorta, JP, Nishiyama, H, Krawczynski, M, Seyitkuliev, A, Novikov, A, Guerrero-Ramos, F, Zukov, R, Kato, M, Kawahara, T, Goeman, L, Puente, J, Hellmis, E, Powles, T, Radziszewski, P, Gust, KM, Vasey, P, Bigot, P, Fradet, Y, Hunting, J, Armstrong, J, Boulos, S, Hois, S, Shore, ND. Durvalumab in combination with BCG for BCG-naive, high-risk, non-muscle-invasive bladder cancer (POTOMAC): final analysis of a randomised, open-label, phase 3 trial. LANCET. 2025; 406(10516)DOI:10.1016/S0140-6736(25)01897-5. PMID:41115436. IF:88.500(Q1/1D).

Barnett-Tapia, C, Vicente, EC, Pascuzzi, RM, Utsugisawa, K, Bloemers, J, Grimson, F, Tarancon, T, Bril, V. Measuring the effect of rozanolixizumab using the Myasthenia Gravis Impairment Index: analyses from the randomized phase 3 MycarinG study. JOURNAL OF NEUROLOGY. 2025; 272(12)DOI:10.1007/s00415-025-13480-8. PMID:41205003. IF:4.600(Q1/2D).

Pasquali, S, Collini, P, Romagosa, C, Coindre, JM, Pizzamiglio, S, Verderio, P, Duroni, V, Barisella, M, Palmerini, E, Quagliuolo, V, Broto, JM, Pousa, AL, Grignani, G, Brunello, A, Blay, JY, Lugowska, I, Fontana, V, Bianchi, G, Palassini, E, Renne, SL, Casali, PG, Miceli, R, Sbaraglia, M, Gambarotti, M, Bagué, S, Dei Tos, AP, Stacchiotti, S, Gronchi, A. Histopathological Response After Neoadjuvant Chemotherapy for High-Risk Soft-Tissue Sarcomas A Secondary Analysis of a Randomized Clinical Trial. JAMA Network Open. 2025; 8(11)DOI:10.1001/jamanetworkopen.2025.40177. PMID:41196599. IF:9.700(Q1/1D).

Lazarus, JV, Agirre-Garrido, L, Miralles-Sanchez, JE, Manolas, MI, Tacke, F, Villela-Nogueira, CA, Al-Omar, HA, Alqahtani, SA, Alzubaidi, LMY, Bansal, M, Cusi, K, Isaacs, SD, Mauricio, D, Miyake, T, Moreira, RO, Nakazawa, S, Pannain, S, Pericàs, JM, Roden, M, Takahashi, H, Brachowicz, N. Cost of Metabolic Dysfunction-Associated Steatotic Liver Disease Screening Among All People Living With Diabetes in Six Countries. LIVER INTERNATIONAL. 2025; 45(12)DOI:10.1111/liv.70390. PMID:41194401. IF:5.200(Q1/2D).

Zafra-Agea, JA, Pérez, TD, Lima-Serrano, M, Vargas-Martinez, AM, Soler-Pardo, E, Torralbas-Ortega, J, Cillero, IH. Availability, perceived need and satisfaction for school nurses in Spain: a cross-sectional study involving the school community. BMC NURSING. 2025; 24(1)DOI:10.1186/s12912-025-03970-5. PMID:41188937. IF:3.900(Q1/1D).

Zaman, A, De Caterina, R, Schiele, F, Sionis, A, Catapano, A, Laufs, U. Cardiologist Attitude to Lipid Control in Patients with ASCVD without Major Cardiovascular Events: Insights from the 2024 ACS EuroPath Survey. CIRCULATION. 2025; 152(SUPPL_3)DOI:10.1161/circ.152.suppl_3.4363828. PMID:. IF:38.600(Q1/1D).

Ramírez-Bermejo, E, Fa-Binefa, M, Pilco-Inga, J, Jordán-Sales, M, Aguilera-Roig, X, González-Rodríguez, JC. Effect of high-pressure pulsatile lavage versus manual rinsing on bone cement penetration in total knee arthroplasty: a randomized clinical trial. Knee Surgery & Related Research. 2025; 37(1)DOI:10.1186/s43019-025-00298-x. PMID:41188974. IF:(Q/D).

Carreras, G, Mendoza, LC, Colom, C, Tirado-Capistros, M, Sardà, H, Sánchez-Quesada, JL, Pérez, A. Thyroid autoimmunity at onset of type 1 diabetes as a predictor of thyroid dysfunction: a thirty-years retrospective longitudinal study. Frontiers in Endocrinology. 2025; 16DOI:10.3389/fendo.2025.1699111. PMID:41255538. IF:4.600(Q1/3D).

Torres-Esquius, S, Gabarros-Subira, M, Rivero, ME, López, GR, Mañó, LG, Lopez, F, Fernandez, C, Guijarro, F, Díaz-Beyá, M, Canela, MP, Acha, P, Jáuregui, SN, Tuset, E, Palomo, L, Valcarcel, D, Albareda, FB, Jerez, A, Montoro, MJ. Performance and clinical utility of germline genetic testing criteria for predisposition to myeloid neoplasms in adults. BLOOD. 2025; 146DOI:10.1182/blood-2025-4998. PMID:. IF:23.100(Q1/1D).

Turki, A, Dall'Olio, D, Carota, L, Polizzi, S, Morote, M, Della Porta, M, Zhao, YM, Lanino, L, Sobas, M, Zhao, YQ, Sanchez, AH, Eric, S, Gimenez, LT, Abáigar, M, Elicegui, JM, Ramiro, AV, Dohner, K, Tettero, J, Esteve, J, Martinez-Lopez, J, Metzeler, K, Haferlach, T, Lehmann, S, Pratcorona, M, Thiede, C, Versluis, J, Mecklenbrauck, R, Heuser, M, Benner, A, Huntley, B, Rivas, JMH, Ossenkoppele, G, Döhner, H, Castellani, G, Bullinger, L. Independent, international validation of the unsupervised harmony classification of Acute Myeloid Leukemia. BLOOD. 2025; 146DOI:10.1182/blood-2025-451. PMID:. IF:23.100(Q1/1D).

Torres-Esquius, S, Gabarros-Subira, M, Gurnari, C, Bravo-Perez, C, López, GR, Arias, RD, Sanz, A, Martinez, MM, Beas, F, Jáuregui, SN, Arias, R, Canela, MP, Saumell, S, Voso, MT, Maciejewski, J, Acha, P, Valcarcel, D, Jerez, A, Montoro, MJ. Bone marrow alterations and clonal hematopoiesis in germline ETV6 mutation carriers without hematologic malignancy. BLOOD. 2025; 146DOI:10.1182/blood-2025-4997. PMID:. IF:23.100(Q1/1D).

Ubieto, AJ, Alós, DG, Dominguez, SR, Magnano, L, Sánchez, S, Vicente, FD, Iacoboni, G, Losada, CM, Manso, RG, Browne, S, Izquierdo, AR, Baumann, T, Bacelar, AG, Santaella, MP, Prieto, PG, De Villambrosia, SG, Bastos-Oreiro, M, Hernandez, AC, De Miguel, LB, Sturla, AL, Abellan, PF, Vidaller, PJP, Amutio, E, Toimil, FS, Pardal, E, Micó, M, Prat, AM, De La Cruz, B, Huerga, S, Landwehr, M, Hernández, I, Andreu, R, De la Cruz, J, Barca, EG. First-line therapy with rituximab vs. rituximab-CHOP in post-transplant monomorphic diffuse large B-cell lymphoma (DLBCL): Long-term real-world evidence from the spanish group of lymphoma (GELTAMO). BLOOD. 2025; 146DOI:10.1182/blood-2025-3677. PMID:. IF:23.100(Q1/1D).

Gurnari, C, Ottone, T, Piciocchi, A, Späth, D, Meid, A, Marsili, G, Fabiani, E, Romano, F, Pascale, MR, Chiusolo, P, Di Ianni, M, Sobas, M, Brunetti, L, Oñate, G, Infante, JB, Nanni, J, Vetro, C, Boada, M, Candoni, A, Sierra, J, Potter, N, Gilkes, A, Johnson, S, Thomas, I, Huntley, B, Russell, N, Dillon, R, Döhner, H, Döhner, K, Voso, MT. Diagnostic evaluation methods and prognostic impact of FLT3-ITD microclones in Acute Myeloid Leukemia (AML): A retrospective multicenter study on behalf of the EHA AML-specialized working group (SWG). BLOOD. 2025; 146DOI:10.1182/blood-2025-217. PMID:. IF:23.100(Q1/1D).

Hernández-Rivas, JA, Prat, AM, Ponce, ES, Medina, A, Lluch-García, R, Oliveira, ACD, Rodriguez-Fernandez, A, Soler, JA, Terol-Castera, MJ, Machado-Machado, P, Pérez-Encinas, M, Romero-Carmona, R, Segundo, LYS, García-Martin, P, Mompo, C, Zubillaga-Marban, E. First worldwide real-life data on fixed-duration ibrutinib plus venetoclax treatment for previously untreated CLL/SLL patients: Updated interim analysis of Spain's LI plus VE observational study. BLOOD. 2025; 146DOI:10.1182/blood-2025-2728. PMID:. IF:23.100(Q1/1D).

Niebla, AM, Gine, E, Bastos-Oreiro, M, Perez, A, Cabirta, A, Vicente, FD, Vilaseca, MC, Ubieto, AJ, De Villambrosia, SG, Prat, AM, Barca, EG, Henriquez, HDL, Herranz, ER, Prieto, PG, Cordoba, R, Carreres, AS, Garcia-Sancho, AM, Moya, AMGN, Grande, C, Martine, PP, Nicolas, C, Gutierrez, A, Rivas, JAH, Sanchez-Gonzalez, B, Villalobos, MT, Garcia-Cerecedo, T, Trillo, RA, Donato, E, Gutierrez, PV, Belmonte, DG, Cozzarelli, SRV, Ordoñez, SS, De La Mano, EP, Avaría, A, Blanco, LV, Roldan-Perez, A, Sancho, JM, De la Cruz, B, Prince-Eladnani, R, Abrisqueta, P. Characterization and outcomes of patients with indolent Mantle Cell Lymphoma (iMCL) in Spain. the GELTAMO-MCL-2022 Study. BLOOD. 2025; 146DOI:10.1182/blood-2025-3592. PMID:. IF:23.100(Q1/1D).

Chatzikonstantinou, T, Agathangelidis, A, Talimtzi, P, Laidou, S, Minga, E, Roussos, A, Angelopoulou, M, De Tomas, MA, Antic, D, Baran-Marszak, F, Bödör, C, Albareda, FB, Catherwood, M, Chatzileontiadou, S, Chessa, C, Coscia, M, Crespo, M, Cuneo, A, Davis, Z, Dimou, M, Doubek, M, Efstathopoulou, M, Espinet, B, Gaidano, G, Gupta, R, Hatzimichael, E, Herishanu, Y, Karamanli, T, Konstantinou, E, Kotsianidis, I, Koumpis, AE, Laszlo, T, Levy, V, Machairas, A, Martini, F, Moia, R, Mouhssine, S, Prat, AM, Murru, R, Mpalaoura, E, Pangalis, G, Papaioannou, M, Pavlova, S, Plevova, K, Pospisilova, S, Puiggros, A, Rani, L, Rigolin, GM, Romano, I, Rossi, D, Serna, A, Simkovic, M, Smolej, L, Stavrogianni, N, Vujovic, KT, Trentin, L, Vassilakopoulos, T, Visentin, A, Vitale, C, Vrachiolias, G, Scarfo, L, Chatzidimitriou, A, Ghia, P, Stamatopoulos, K. Dissecting the heterogeneity of IGHV-mutated CLL: An eric study. BLOOD. 2025; 146DOI:10.1182/blood-2025-2120. PMID:. IF:23.100(Q1/1D).

Bastos-Oreiro, M, Cabirta, A, Perez, A, Carreres, AS, De Villambrosia, SG, Canelo, M, Moya, AMGN, Benito, BD, Gutiérrez, PV, Vicente, FD, Caballero, JC, Jiménez-Ubieto, A, Belmonte, DG, Prat, AM, Barca, EG, Henríquez, HDL, Herranz, ER, Garcia-Sancho, AM, Grande, C, Nicolás, C, Gutierrez, A, Gomez-Llobell, M, Rivas, JAH, Sánchez-González, B, Campos, AF, Trillo, RA, Donato, E, Cozzarell, SRV, Ordoñez, SS, De La Mano, EP, Prieto, PG, Avaria, A, Blanco, LV, Roldán-Pérez, A, Cordoba, R, Sancho, JM, Gine, E, Garces, VN, Abrisqueta, P, Niebla, AM. Central nervous system involvement in Mantle Cell Lymphoma: A retrospective multicenter cohort study from the spanish geltamo group. BLOOD. 2025; 146DOI:10.1182/blood-2025-3585. PMID:. IF:23.100(Q1/1D).